Jump to content

Astromech (company): Difference between revisions

From IdeaWazaWiki
Newer edit →

Idea (talk | contribs)

3 user groups
94 edits
by https://en.wikipedia.org/w/index.php?title=Astromech_(company)&action=history
 
(No difference)

Revision as of 05:55, 28 September 2026

This article is being considered for deletion in accordance with Wikipedia's deletion policy.
Please share your thoughts on the matter at this article's entry on the Articles for deletion page.
Feel free to edit the article, but the article must not be blanked, and this notice must not be removed, until the discussion is closed. For more information, particularly on merging or moving the article during the discussion, read the Guide to deletion.

Steps to list an article for deletion:

  1. {{afd}}
  2. Preloaded debate OR {{afd2|pg=Astromech (company)|cat=|text=}} ~~~~ (categories)
  3. {{afd3|pg=Astromech (company)}} (add to top of list)
  4. Please consider notifying the author(s) by placing {{adw|Astromech (company)}} ~~~~ on their talk page(s).

Unregistered users placing this tag on an article cannot complete the deletion nomination and should leave detailed reasons for deletion on Talk:Astromech (company). If the nomination is not completed and no message is left on the talkpage, this tag may be removed.

Template:Short description Template:Infobox company

Astromech AI Corp. is an American startup building a predictive engine for biology using genomic data.[1] It has operated in stealth mode since August 2025 with plans to become a warning system for evolution by "predicting where biological systems are going, identifying where biological systems may be vulnerable and why those changes could be happening" to forecast disease risk, drug resistance, food supply chain threats and system vulnerabilities.[2][3]

Founders Ben Lamm and George Church initially raised $30 million in funding and closed an additional $10.5 million in March 2026, valuing the company at $2 billion.[4][3] In August 2026, Astromech's valuation nearly doubled to $3.8 billion after $20 million in further funding to expand its research team and scale how it trains its AI models.[2][5] The company's first model is working to generate hypotheses for the biological sources of longevity, having mapped 46 genes for cellular maintenance and cancer resistance to date.[6]

The company's name is a reference to Astromech droids in Star Wars.[7]

References

  1. ↑ Knapp, Alex (21 August 2026). "This Billionaire Is Using AI To Forecast Evolutionary Change". https://www.forbes.com/sites/the-prototype/2026/08/21/this-billionaire-is-using-ai-to-forecast-evolutionary-change/. 
  2. ↑ 2.0 2.1 Richie, Sasha (20 August 2026). "Colossal AI spinoff hits $3.8 billion valuation, targets aging with first model". https://www.dallasnews.com/business/technology/article/astromech-colossal-biological-ai-startup-funding-22394802.php. 
  3. ↑ 3.0 3.1 Sechler, Bob; Wistrom, Brent (14 August 2025). "Colossal Biosciences co-founders raise funds for new biology-focused AI startup". https://www.bizjournals.com/austin/news/2025/08/14/astromech-colossal-biosciences-ai-austin-biology.html. 
  4. ↑ Cite error: Invalid <ref> tag; no text was provided for refs named dmagazine
  5. ↑ Shen, Lucinda (20 August 2026). "Colossal spin-off Astromech hits $3.8B valuation". https://www.axios.com/pro/biotech-deals/2026/08/20/colossal-spin-off-astromech-double-valuation. 
  6. ↑ Heilweil, Rebecca (20 August 2026). "How Colossal is incubating an empire of startups". https://www.fastcompany.com/91592688/how-colossal-is-incubating-an-empire-of-startups. 
  7. ↑ Rosas, Leonardo (3 April 2026). "Dallas billionaire sees second startup achieve unicorn status". https://www.bizjournals.com/dallas/news/2026/04/03/benjamin-lamm-ai-startup-astromech-2-billion-valua.html. 
Retrieved from "https://ideawaza.com/index.php?title=Astromech_(company)&oldid=70631"